Medical Crossfire: Turning Therapeutic Innovation Into Practice—Personalizing Care in Multiple Myeloma
Friday, May 15th, 09:15-10:30

Upon completion of this activity, learners will be better able to:

  • Evaluate recent efficacy and safety data from pivotal trials assessing new and emerging therapies for MM
  • Apply disease-specific and individual patient considerations to optimize personalized treatment planning in MM
  • Assess the evolving evidence on using MRD assessments to guide the choice and duration of maintenance therapy
  • Implement the latest best practices for preventing and managing treatment-related toxicities in patients with MM
AGENDA
5 min Faculty introductions, program overview, and pre-activity assessment questions
15 min
Medical Crossfire® Debate
  • Should every transplant-eligible patient receive quadruplet therapy? 15 min Medical Crossfire® Debate
15 min
Medical Crossfire® Debate
  • How do you chose between Daratumumab v Isatuximab?
    • Cover administration / on body system
15 min
Medical Crossfire® Debate
  • How do sequence CART, bispecific, ADC therapies?
15 min
Panel Discussion
Future directions/new therapies: panel discussion touching on new MoAs and where we are going?
10 min
Post-activity assessment questions, faculty Q&A session, and concluding remarks